These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 3938264

  • 1. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 2. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF.
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [Abstract] [Full Text] [Related]

  • 3. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
    Fauchier JP, Cosnay P, Moquet B, Rouesnel P, Kapusta P, Vrancea F.
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
    [Abstract] [Full Text] [Related]

  • 4. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern.
    Antunes E, da Silva N, Catarino C, Serra J, Galrinho A, Ferreira R, Quininha J, Gracias R, Rato JA.
    Rev Port Cardiol; 1993 Apr; 12(4):333-6. PubMed ID: 8512728
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M.
    Indian Heart J; 1991 Apr; 43(1):5-10. PubMed ID: 1894303
    [Abstract] [Full Text] [Related]

  • 6. Accessory pathway reciprocating tachycardia.
    Obel OA, Camm AJ.
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [Abstract] [Full Text] [Related]

  • 7. [Surgical atrioventricular disconnection in Wolff-Parkinson-White syndrome].
    Pavie A, Mesnildrey P, Gandjbakhch I, Cabrol C, Fontaine G, Franck R, Grosgogeat Y, Slama R.
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):606-15. PubMed ID: 6431924
    [Abstract] [Full Text] [Related]

  • 8. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH, Leitch JW, Klein GJ, Yee R, Leather RA.
    Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
    [Abstract] [Full Text] [Related]

  • 9. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
    Kieny JR, Kraenner C, Facello A, Roul G, Mossard JM, Bareiss P, Sacrez A.
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
    [Abstract] [Full Text] [Related]

  • 10. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Jun; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 12. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B, Miquel JP, Puel JP, Mordant B, Kher A, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
    Fauchier JP, Cosnay P, Néel C, Rouesnel P, Bonnet P, Quilliet L.
    Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
    [Abstract] [Full Text] [Related]

  • 14. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M.
    Indian Heart J; 1996 Apr; 48(2):133-7. PubMed ID: 8682552
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 16. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M, Breithardt G.
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [Abstract] [Full Text] [Related]

  • 17. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
    Dolla E, Levy S, Cointe R, Moyal C, Bru P, Rossi P, Gérard R.
    Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709
    [Abstract] [Full Text] [Related]

  • 18. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 19. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 01; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

  • 20. [Value of flecainide in supraventricular arrhythmias].
    Chouty F, Leclercq JF, Coumel P.
    Ann Cardiol Angeiol (Paris); 1986 Apr 01; 35(4):237-41. PubMed ID: 3740779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.